Clinical Trial Update: D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates ongoing Phase 1/2 studies of D2C7-IT and 2141-V11 for newly diagnosed MGMT unmethylated glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 2141-V11
• D2C7-IT

Snippet

Sponsor: Darell Bigner | Conditions: Newly Diagnosed MGMT Unmethylated Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING